← Back to catalog
Genetic Testing
Diagnosis of Ph-Negative Chronic Myeloproliferative Neoplasms. JAK2 V617F Mutation (qualitative)
2 900 som
Turnaround: 7–14 business days
Blood draw — 80 som (included in packages)
Description
A specialized cancer-genetics test (JAK2 V617F mutation, qualitative, for myeloproliferative disorders). Ordered by an oncologist/hematologist to clarify diagnosis and guide targeted therapy.
When to Take This Test
- As directed by an oncologist/hematologist
- Diagnosis and treatment selection
- Monitoring therapy
Preparation
- Preparation follows the lab's instructions
- Ordered and interpreted by an oncologist/hematologist
This information is for reference only and does not replace a doctor's consultation.
Not sure which test you need?
Ask a question on WhatsAppSimilar tests
- Diagnosis of Ph-Negative Chronic Myeloproliferative Neoplasms. JAK2 V617F Mutation (quantitative)2 900 som
- BRCA1 and BRCA2 Mutation Detection by NGS (full coding region sequencing) (blood)2 960 som
- Type 2 Diabetes Predisposition Gene2 800 som
- Predisposition to Obesity and Type 2 Diabetes2 800 som
- Predisposition to Coronary Heart Disease "IHD Screen"2 800 som
- HLA-B51 Typing for Behçet's Disease2 700 som